FrancophonIA/ELRC3.0 huggingface dataset:
English: Sixty per cent (60%) of patients in the placebo group reached this target blood pressure whereas this figure was 76% and 78% in the irbesartan and amlodipine groups respectively.
Croatian: U skupini koja je primala placebo 60% bolesnika postiglo je ciljni krvni tlak dok je ta vrijednost bila 76% u skupini koja je primala irbesartan, odnosno 78% u skupini koja je primala amlodipin.
English: 14 - 28 - 56 - 98 tablets: Mon
Croatian: 14 - 28 - 56 - 98 tableta: PON
English: In diabetic hypertensive patients with microalbuminuria and normal renal function, orthostatic dizziness and orthostatic hypotension were reported in 0.5% of the patients (i.e., uncommon) but in excess of placebo.
Croatian: U bolesnika koji boluju od hipertenzije i šećerne bolesti s mikroalbuminurijom i normalnom bubrežnom funkcijom prijavljene su ortostatska omaglica i ortostatska hipotenzija u njih 0,5%, dakle manje često, ali s većom učestalošću nego kod placeba.
English: Potassium supplements and potassium-sparing diuretics: based on experience with the use of other medicinal products that affect the renin-angiotensin system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other medicinal products that may increase serum potassium levels (e.g. heparin) may lead to increases in serum potassium and is, therefore, not recommended (see section 4.4).
Croatian: Nadomjesci kalija i diuretici koji štede kalij: na temelju iskustva s ostalim lijekovima koji utječu na renin-angiotenzinski sustav, istodobno uzimanje diuretika koji štede kalij, nadomjestaka kalija, nadomjestaka soli koji sadrže kalij ili ostalih lijekova koji mogu povećati serumsku razinu kalija (npr. heparin) može izazvati porast serumskog kalija te se, stoga, ne preporučuje (vidjeti dio 4.4).
English: Undesirable effects where the frequency is not known are: feeling of spinning, headache, taste disturbance, ringing in the ears, muscle cramps, pain in joints and muscles, reduced number of platelets, abnormal liver function, increased blood potassium levels, impaired kidney function, inflammation of small blood vessels mainly affecting the skin (a condition known as leukocytoclastic vasculitis),and severe allergic reactions (anaphylactic shock).
Croatian: Nuspojave čija učestalost nije poznata su: vrtoglavica, glavobolja, poremećaji okusa, zvonjenje u ušima, grčevi u mišićima, bol u zglobovima i mišićima, smanjen broj krvnih pločica, poremećaj funkcije jetre, povišena razina kalija u krvi, oslabljena funkcija bubrega, upala malih krvnih žila koja uglavnom zahvaća kožu (stanje poznato kao leukocitoklastični vaskulitis) i teške alergijske reakcije (anafilaktički šok).
English: Aprovel is not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).
Croatian: Ne smijete ga uzimati nakon trećeg mjeseca trudnoće jer može ozbiljno naškoditi Vašem djetetu ako ga uzimate u tom stadiju (vidjeti dio o trudnoći).
English: No dosage adjustment is necessary in female patients.
Croatian: Stoga nije potrebna prilagodba doze u žena.
English: No dosage adjustment is necessary in patients with impaired renal function.
Croatian: Nije potrebna prilagodba doze u bolesnika s oštećenom funkcijom bubrega.
English: Should exposure to AIIRAs have occurred from the second trimester of pregnancy, ultrasound check of renal function and skull is recommended.
Croatian: Ako je došlo do izloženosti antagonistima receptora angiotenzina II od drugog tromjesečja trudnoće nadalje, preporučuje se ultrazvučni pregled funkcije bubrega i lubanje.
English: Very common: Hyperkalaemia* occurred more often in diabetic patients treated with irbesartan than with placebo.
Croatian: hiperkalijemija* se javljala češće u bolesnika sa šećernom bolešću liječenih irbesartanom nego u skupini koja je primala placebo.
English: In hypertensive type 2 diabetic patients, therapy should be initiated at 150 mg irbesartan once daily and titrated up to 300 mg once daily as the preferred maintenance dose for treatment of renal disease.
Croatian: U hipertenzivnih bolesnika sa šećernom bolešću tipa 2 liječenje treba započeti sa 150 mg irbesartana jedanput na dan i dozu titrirati do 300 mg jedanput na dan, što je doza održavanja koja se preporučuje za liječenje bubrežne bolesti.
English: Pharmacotherapeutic group: Angiotensin-II antagonists, plain.
Croatian: Farmakoterapijska skupina: antagonisti angiotenzina II, čisti.
English: vertigo, headache Ear and labyrinth disorder Not known:
Croatian: vrtoglavica, glavobolja Poremećaji uha i labirinta Nepoznato:
English: A lower starting dose (75 mg) should be considered for patients undergoing haemodialysis (see section 4.4).
Croatian: U bolesnika na hemodijalizi treba razmotriti započinjanje liječenja nižom početnom dozom od 75 mg (vidjeti dio 4.4).
English: Common (may affect up to 1 in 10 people): dizziness, feeling sick/vomiting, fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme).
Croatian: Često (mogu se javiti u manje od 1 na 10 osoba): omaglica, mučnina/povraćanje, umor, a krvne pretrage mogu pokazati povišenu razinu enzima specifičnog za mišićnu i srčanu funkciju (enzim kreatinin kinaza).
English: In diabetic hypertensive patients with chronic renal insufficiency and overt proteinuria, hyperkalaemia (≥ 5.5 mEq/L) occurred in 46.3% of the patients in the irbesartan group and 26.3% of the patients in the placebo group.
Croatian: U bolesnika sa šećernom bolešću i hipertenzijom s kroničnom bubrežnom insuficijencijom i manifestnom proteinurijom, hiperkalijemija (≥ 5,5 mEq/L) se razvila u 46,3% bolesnika koji su primali irbesartan te u 26,3% bolesnika u placebo skupini.
English: leukocytoclastic vasculitis
Croatian: leukocitoklastični vaskulitis
English: The demonstration of renal benefit of Aprovel in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see sections 4.3, 4.4, 4.5 and 5.1).
Croatian: Dokaz koristi lijeka Aprovel na bubrežnu funkciju u hipertenzivnih bolesnika sa šećernom bolešću tipa 2 zasniva se na ispitivanjima u kojima se irbesartan prema potrebi uzimao kao dopuna ostaloj antihipertenzivnoj terapiji za postizanje ciljnog krvnog tlaka (vidjeti dijelove 4.3, 4.4, 4.5 i 5.1).
English: Irbesartan exhibits linear and dose proportional pharmacokinetics over the dose range of 10 to 600 mg. A less than proportional increase in oral absorption at doses beyond 600 mg (twice the maximal recommended dose) was observed; the mechanism for this is unknown.
Croatian: Zabilježen je neproporcionalan porast u oralnoj apsorpciji pri dozama većima od 600 mg (doza dvostruko veća od maksimalne preporučene doze), ali mehanizam ovoga je nepoznat.
English: Peak reduction of blood pressure is achieved within 3-6 hours after administration and the blood pressure lowering effect is maintained for at least 24 hours.
Croatian: Najveće sniženje tlaka postiže se unutar 3-6 sati nakon primjene, a učinak sniženog tlaka održava se najmanje 24 sata.
English: If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Aprovel” and “Warnings and precautions”).
Croatian: “Nemojte uzimati Aprovel” i “Upozorenja i mjere opreza”).
English: In this case your doctor may perform regular blood tests, especially for measuring blood potassium levels in case of poor kidney function if you are going to have an operation (surgery) or be given anaesthetics if you are taking any of the following medicines used to treat high blood pressure: o an ACE-inhibitor ( for example enalapril, lisinopril, ramipril) in particular if you have diabetes-related kidney problems.
Croatian: U tom će Vam slučaju Vaš liječnik možda raditi redovite pretrage krvi, posebno određivanje koncentracije kalija u krvi u slučaju oslabljene funkcije bubrega ako trebate ići na bilo kakav kirurški zahvat ili trebate primiti anestetike ako uzimate bilo koji od lijekova navedenih u nastavku, koji se koriste za liječenje visokog krvnog tlaka: ACE inhibitor (primjerice enalapril, lisinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću. aliskiren Liječnik Vam može provjeravati bubrežnu funkciju, krvni tlak i količinu elektrolita (npr. kalija) u krvi u redovitim intervalima.
English:  The other ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, hypromellose, silicon dioxide, magnesium stearate, titanium dioxide, macrogol 3000, carnauba wax.
Croatian: Drugi sastojci su laktoza hidrat, mikrokristalična celuloza, umrežena karmelozanatrij, hipromeloza, silicijev dioksid, magnezijev stearat, titanijev dioksid, makrogol 3000, karnauba vosak.
English: What Aprovel contains  The active substance is irbesartan.
Croatian: Djelatna tvar je irbesartan.
English: How to store Aprovel
Croatian: Kako čuvati Aprovel
English: The dose may later be increased to 300 mg once daily depending on blood pressure response.
Croatian: Doza se kasnije može povećati na 300 mg jedanput na dan, ovisno o vrijednostima krvnog tlaka.
English: Steady-state plasma concentrations are attained within 3 days after initiation of a once-daily dosing regimen.
Croatian: Koncentracija u plazmi u stanju dinamičke ravnoteže postiže se 3 dana nakon uvođenja doziranja jedanput na dan.
English: The “Irbesartan Diabetic Nephropathy Trial (IDNT)” shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria.
Croatian: Kliničko ispitivanje „Ispitivanje irbesartana u bolesnika s dijabetičkom nefropatijom“ (Irbesartan Diabetic Nephropathy Trial, IDNT) pokazuje da irbesartan smanjuje progresiju bubrežne bolesti u bolesnika s kroničnom bubrežnom insuficijencijom i manifestnom proteinurijom.
English: Renovascular hypertension: there is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system.
Croatian: Renovaskularna hipertenzija: povećan je rizik od teške hipotenzije i insuficijencije bubrega u bolesnika koji se liječe lijekovima koji utječu na renin-angiotenzinski sustav, a imaju obostranu stenozu bubrežnih arterija ili stenozu arterije u jedinom funkcionalnom bubregu.
English: Lithium: reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Croatian: Litij: tijekom istodobne primjene litija i inhibitora angiotenzin konvertirajućeg enzima prijavljen je reverzibilan porast koncentracije serumskog litija i njegove toksičnosti.
English: No dosage adjustment is necessary in patients with mild to moderate hepatic impairment.
Croatian: Nije potrebna prilagodba doze u bolesnika s blagim do umjerenim oštećenjem funkcije jetre.
English: The dose may later be increased to 300 mg (four tablets a day) once daily depending on blood pressure response.
Croatian: Doza se kasnije može povećati na 300 mg (četiri tablete na dan) jedanput na dan, ovisno o vrijednostima krvnog tlaka.
English: The efficacy of Aprovel is not influenced by age or gender.
Croatian: Dob i spol ne utječu na djelotvornost lijeka Aprovel.
English: The decrease in blood pressure is dose-related for once a day doses with a tendency towards plateau at doses above 300 mg. Doses of 150-300 mg once daily lower supine or seated blood pressures at trough (i.e. 24 hours after dosing) by an average of 8-13/5-8 mm Hg (systolic/diastolic) greater than those associated with placebo.
Croatian: Doze od 150-300 mg jedanput na dan smanjuju krvni tlak u ležećem ili sjedećem položaju u vrijeme najniže koncentracije u krvi (to jest 24 sata nakon uzimanja doze) i to u prosjeku za 8-13/5-8 mmHg (sistolički/dijastolički) više od placeba.
English: At the end of the three weeks the mean reduction from baseline in the primary efficacy variable, trough seated systolic blood pressure (SeSBP) was 11.7 mmHg (low dose), 9.3 mmHg (medium dose), 13.2 mmHg (high dose).
Croatian: Nakon tri tjedna srednja vrijednost smanjenja krvnog tlaka u odnosu na početne vrijednosti za primarnu varijablu djelotvornosti, sistolički krvni tlak u sjedećem položaju kod najniže koncentracije u krvi (SjSKT), iznosila je 11,7 mmHg (niska doza), 9,3 mmHg
English: Aprovel is for oral use.
Croatian: Aprovel je namijenjen za primjenu kroz usta.
English: Each tablet of Aprovel 75 mg contains 75 mg irbesartan.
Croatian: Jedna Aprovel 75 mg tableta sadrži 75 mg irbesartana.
English: The dose may later be increased to 300 mg (two tablets a day) once daily depending on blood pressure response.
Croatian: Doza se kasnije može povećati na 300 mg (dvije tablete na dan) jedanput na dan, ovisno o vrijednostima krvnog tlaka.
English: The most likely manifestations of overdose are expected to be hypotension and tachycardia; bradycardia might also occur from overdose.
Croatian: Najčešće očekivane manifestacije predoziranja su hipotenzija i tahikardija.
English: Lactose monohydrate Hypromellose Titanium dioxide Macrogol 3000
Croatian: Film-ovojnica: laktoza hidrat hipromeloza titanijev dioksid makrogol 3000 karnauba vosak
English: Each tablet of Aprovel 150 mg contains 150 mg irbesartan.
Croatian: Jedna Aprovel 150 mg tableta sadrži 150 mg irbesartana.
English: Unless continued AIIRA therapy is considered essential, patients planning pregnancy should be changed to alternative antihypertensive treatments which have an established safety profile for use in pregnancy.
Croatian: Osim ako se nastavak terapije antagonistima receptora angiotenzina II ne smatra neophodnim, bolesnice koje planiraju trudnoću trebaju prijeći na alternativnu antihipertenzivnu terapiju s utvrđenom sigurnošću primjene u trudnoći.
English: Uncommon (may affect up to 1 in 100 people): heart rate increased, flushing, cough, diarrhoea, indigestion/heartburn, sexual dysfunction (problems with sexual performance), chest pain.
Croatian: Manje često (mogu se javiti u manje od 1 na 100 osoba): ubrzan srčani ritam, crvenilo praćeno osjećajem vrućine, kašalj, proljev, probavni poremećaji/žgaravica, problemi sa seksualnom funkcijom, bol u prsištu.
English: While similar blood pressure was achieved in all treatment groups, fewer subjects in the irbesartan 300 mg group (5.2%) than in the placebo (14.9%) or in the irbesartan 150 mg group (9.7%) reached the endpoint of overt proteinuria, demonstrating a 70% relative risk reduction versus placebo (p = 0.0004) for the higher dose.
Croatian: Dok je sličan krvni tlak postignut u svim ispitivanim skupinama, manje bolesnika u skupini koja je primala 300 mg irbesartana (5,2%) dostiglo je mjeru ishoda manifestne proteinurije u odnosu na skupinu koja je primala placebo (14,9%)
English: In the female and black subgroups which represented 32% and 26% of the overall study population respectively, a renal benefit was not evident, although the confidence intervals do not exclude it. As for the secondary endpoint of fatal and non-fatal cardiovascular events, there was no difference among the three groups in the overall population, although an increased incidence of non-fatal MI was seen for women and a decreased incidence of non-fatal MI was seen in males in the irbesartan group versus the placebobased regimen.
Croatian: Za sekundarnu mjeru ishoda ispitivanja, fatalne i nefatalne kardiovaskularne događaje, u sveukupnoj ispitivanoj populaciji nije bilo razlika između tri skupine, iako je zabilježena povećana incidencija nefatalnog infarkta miokarda u žena i smanjena incidencija nefatalnog infarkta miokarda u muškaraca u skupini koja je primala irbesartan u odnosu na onu koja je primala placebo.
English: Each tablet of Aprovel 300 mg contains 300 mg irbesartan.
Croatian: Jedna Aprovel 300 mg tableta sadrži 300 mg irbesartana.
English: hepatitis, abnormal liver function Skin and subcutaneous tissue disorders Not known:
Croatian: Poremećaji kože i potkožnog tkiva Nepoznato:
English: NAME OF THE MEDICINAL PRODUCT Aprovel 300 mg tablets irbesartan STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 300 mg LIST OF EXCIPIENTS Excipients: also contains lactose monohydrate.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA NAZIV LIJEKA Aprovel 300 mg tablete irbesartan NAVOĐENJE DJELATNE(IH) TVARI Jedna tableta sadrži 300 mg irbesartana POPIS POMOĆNIH TVARI Pomoćne tvari: također sadrži laktozu hidrat.
English: If you take more Aprovel than you should If you accidentally take too many tablets, contact your doctor immediately.
Croatian: Ako slučajno uzmete previše tableta, odmah se obratite svom liječniku.
English: Exposure to AIIRA therapy during the second and third trimesters is known to induce human foetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia).
Croatian: Poznato je da u ljudi terapija antagonistima receptora angiotenzina II tijekom drugog i trećeg tromjesečja izaziva fetotoksičnost (smanjena bubrežna funkcija, oligohidramnion, usporavanje okoštavanja lubanje) i neonatalnu toksičnost (zatajenje bubrega, hipotenzija, hiperkalijemija) (vidjeti dio 5.3).
English: The use of AIIRAs is contraindicated during the second and third trimesters of pregnancy (see sections 4.3 and 4.4).
Croatian: Uzimanje antagonista receptora angiotenzina II ne preporučuje se tijekom prvog tromjesečja trudnoće (vidjeti dio 4.4), a kontraindicirano je tijekom drugog i trećeg tromjesečja (vidjeti dijelove 4.3 i 4.4).
English: Less than 2% of the dose is excreted in the urine as unchanged irbesartan.
Croatian: doze izlučuje se u obliku nepromijenjenog irbesartana.
English: thrombocytopenia Immune system disorders Not known:
Croatian: Poremećaji imunološkog sustava Nepoznato:
English: NAME OF THE MEDICINAL PRODUCT Aprovel 150 mg tablets irbesartan STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains: irbesartan 150 mg LIST OF EXCIPIENTS Excipients: also contains lactose monohydrate.
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA NAZIV LIJEKA Aprovel 150 mg tablete irbesartan NAVOĐENJE DJELATNE(IH) TVARI Jedna tableta sadrži 150 mg irbesartana POPIS POMOĆNIH TVARI Pomoćne tvari: također sadrži laktozu hidrat.
English: Aprovel 75 mg film-coated tablets irbesartan
Croatian: Aprovel 75 mg filmom obložene tablete irbesartan
English: Diuretics and other antihypertensive agents: other antihypertensive agents may increase the hypotensive effects of irbesartan; however Aprovel has been safely administered with other antihypertensive agents, such as beta-blockers, long-acting calcium channel blockers, and thiazide diuretics.
Croatian: Aprovel se, međutim, pokazao sigurnim za primjenu s ostalim antihipertenzivnim lijekovima poput beta blokatora, dugodjelujućih blokatora kalcijevih kanala i tiazida.
English: Experience in adults exposed to doses of up to 900 mg/day for 8 weeks revealed no toxicity.
Croatian: Iskustvo je pokazalo da nije bilo toksičnog djelovanja irbesartana u odraslih ljudi koji su bili izloženi dozama do 900 mg/dan tijekom 8 tjedana.
English: Unidose blister packs of 56 x 1 tablet for delivery in hospitals are also available.
Croatian: Dostupna su i pakiranja s 56 x 1 tabletom u blisterima djeljivim na jedinične doze za primjenu u bolnicama.
English: Do not take Aprovel  if you are allergic to irbesartan or any other ingredients of this medicine (listed in section 6)  if you are more than 3 months pregnant.
Croatian: Nemojte uzimati Aprovel ako ste alergični na irbesartan ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.) ako ste trudni više od 3 mjeseca (također se preporučuje izbjegavati Aprovel i u ranoj trudnoći - vidjeti dio o trudnoći) ako imate šećernu bolest ili oštećenu bubrežnu funkciju i liječite se lijekom za snižavanje krvnog tlaka koji sadrži aliskiren
English: Sanofi S.p.A. Tel: 800.536389
Croatian: Tel: 800.536389
English: Studies have not been performed in patients with severe hepatic impairment.
Croatian: Nisu provedena ispitivanja u bolesnika s teškim oštećenjem funkcije jetre.
English: In 1.7% of hypertensive patients with advanced diabetic renal disease treated with irbesartan, a decrease in haemoglobin*, which was not clinically significant, has been observed.
Croatian: Smanjenje razine hemoglobina*, koje nije bilo klinički značajno, zabilježeno je u 1,7% hipertenzivnih bolesnika s uznapredovalom dijabetičkom bubrežnom bolešću koji su primali irbesartan.
English: Aliskiren-containing products or ACE-inhibitors: clinical trial data has shown that dual blockade of the renin-angiotensin-aldosterone system (RAAS) through the combined use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren is associated with a higher frequency of adverse events such as hypotension, hyperkalaemia and decreased renal function (including acute renal failure) compared to the use of a single RAAS-acting agent (see sections 4.3, 4.4 and 5.1).
Croatian: Lijekovi koji sadrže aliskiren ili ACE inhibitori: podaci iz kliničkih ispitivanja pokazali su da je dvostruka blokada renin-angiotenzin-aldosteronskog sustava (RAAS) kombiniranom primjenom ACE inhibitora, blokatora angiotenzin II receptora ili aliskirena povezana s većom učestalošću štetnih događaja kao što su hipotenzija, hiperkalemija i smanjena bubrežna funkcija (uključujući akutno zatajenje bubrega) u usporedbi s primjenom samo jednog lijeka koji djeluje na RAAS (vidjeti dijelove 4.3, 4.4 i 5.1).
English: Unidose blister packs of 56 x 1 film-coated tablet for delivery in hospitals are also available.
Croatian: Dostupna su i pakiranja s 56 x 1 filmom obloženom tabletom u blisterima djeljivim na jedinične doze za primjenu u bolnicama.
English: Serum potassium levels are not significantly affected by irbesartan alone at the recommended doses.
Croatian: Pri preporučenim dozama irbesartan ne utječe značajno na razinu serumskog kalija.
English: When pregnancy is diagnosed, treatment with AIIRAs should be stopped immediately, and, if appropriate, alternative therapy should be started.
Croatian: Ako se utvrdi trudnoća, mora se odmah prekinuti terapija antagonistima receptora angiotenzina II te, ako je to primjereno, uvesti drugu terapiju.
English: Uncommon: diarrhoea, dyspepsia/heartburn Not known:
Croatian: Manje često: proljev, dispepsija/žgaravica Nepoznato:
English:  The other ingredients are microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, colloidal hydrated silica, pregelatinised maize starch, and poloxamer 188.
Croatian: Drugi sastojci su mikrokristalična celuloza, umrežena karmelozanatrij, laktoza hidrat, magnezijev stearat, koloidni hidratizirani silicijev dioksid, prethodno geliran kukuruzni škrob i poloksamer 188. Vidjeti dio 2., „Aprovel sadrži laktozu”
English: Valsartan
Croatian: KUTIJA
English: However, initiation of therapy with 75 mg could be considered, particularly in haemodialysed patients and in the elderly over 75 years.
Croatian: Međutim, u bolesnika na hemodijalizi i u bolesnika starijih od 75 godina može se razmotriti započinjanje terapije dozom od 75 mg.
English: Cartons of 56 x 1 tablet in PVC/PVDC/Aluminium perforated unit dose blisters.
Croatian: Kutija s 56 x 1 tabletom u PVC/PVDC/aluminij perforiranim blisterima djeljivim na jedinične doze.
English: Cardiac disorders Uncommon: tachycardia Vascular disorders Common:
Croatian: Srčani poremećaji Manje često: tahikardija Krvožilni poremećaji Često:
English: Sun
Croatian: NED
English: Aprovel 150 mg film-coated tablets irbesartan
Croatian: Aprovel 150 mg filmom obložene tablete irbesartan
English: Aprovel 300 mg film-coated tablets irbesartan
Croatian: Aprovel 300 mg filmom obložene tablete irbesartan